Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bailey PSJ"'
Autor:
Costa Ash., James A. Nathan, Robin Antrobus, Bailey Psj, Brian Ortmann, Christian Frezza, Jack W. Houghton
2-oxoglutarate (2-OG or α-ketoglutarate) relates mitochondrial metabolism to cell function by modulating the activity of 2-OG dependent dioxygenases (2-OG DDs) involved in the hypoxia response and DNA/histone modifications. However, metabolic pathwa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e2c5d1f97a60b5fc00ce5ef1fb7ecec
https://doi.org/10.1101/2020.04.18.048082
https://doi.org/10.1101/2020.04.18.048082
Autor:
Wit N; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK., Gogola E; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK., West JA; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Vornbäumen T; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Seear RV; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Bailey PSJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Burgos-Barragan G; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Wang M; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK., Krawczyk P; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK., Huberts DHEW; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Gergely F; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Department of Biochemistry, University of Oxford, Oxford, UK., Matheson NJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.; NHS Blood and Transplant, Cambridge, UK., Kaser A; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Cambridge, Cambridge, UK., Nathan JA; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Department of Medicine, University of Cambridge, Cambridge CB2 0AW, UK., Patel KJ; MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Publikováno v:
Science advances [Sci Adv] 2023 May 19; Vol. 9 (20), pp. eadg2235. Date of Electronic Publication: 2023 May 17.
Autor:
Ortmann BM; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Burrows N; Cambridge Institute for Medical Research, The Keith Peters Building, Department of Medicine, University of Cambridge, Cambridge, UK., Lobb IT; Cambridge Institute for Medical Research, The Keith Peters Building, Department of Medicine, University of Cambridge, Cambridge, UK., Arnaiz E; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Wit N; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Bailey PSJ; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Jordon LH; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Lombardi O; NDM Research Building, University of Oxford, Headington, Oxford, UK., Peñalver A; Cambridge Institute for Medical Research, The Keith Peters Building, Department of Medicine, University of Cambridge, Cambridge, UK., McCaffrey J; Cambridge Institute for Medical Research, The Keith Peters Building, Department of Medicine, University of Cambridge, Cambridge, UK.; Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK., Seear R; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK., Mole DR; NDM Research Building, University of Oxford, Headington, Oxford, UK., Ratcliffe PJ; Ludwig Institute for Cancer Research, University of Oxford, Headington, Oxford, UK.; The Francis Crick Institute, London, UK., Maxwell PH; Cambridge Institute for Medical Research, The Keith Peters Building, Department of Medicine, University of Cambridge, Cambridge, UK., Nathan JA; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK. jan33@cam.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2021 Jul; Vol. 53 (7), pp. 1022-1035. Date of Electronic Publication: 2021 Jun 21.
Autor:
Bailey PSJ; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK., Ortmann BM; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK., Martinelli AW; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK., Houghton JW; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK., Costa ASH; MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK.; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 11724, USA., Burr SP; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, CB2 0XY, UK., Antrobus R; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK., Frezza C; MRC Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK., Nathan JA; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge, CB2 0XY, UK. jan33@cam.ac.uk.; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW, UK. jan33@cam.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Aug 13; Vol. 11 (1), pp. 4046. Date of Electronic Publication: 2020 Aug 13.
Autor:
Bailey PSJ; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, CB2 0XY Cambridge, United Kingdom., Hiltunen JK; Faculty of Biochemistry and Molecular Medicine, University of Oulu, FIN-90014 Oulu, Finland., Dieckmann CL; Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721 dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk., Kastaniotis AJ; Faculty of Biochemistry and Molecular Medicine, University of Oulu, FIN-90014 Oulu, Finland; dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk., Nathan JA; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, CB2 0XY Cambridge, United Kingdom; dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2018 Aug 07; Vol. 115 (32), pp. E7458-E7459. Date of Electronic Publication: 2018 Jul 24.
Autor:
Bailey PSJ; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge CB2 0XY, UK. psjb3@cam.ac.uk., Nathan JA; Cambridge Institute for Medical Research, Department of Medicine, University of Cambridge, Cambridge CB2 0XY, UK. jan33@cam.ac.uk.
Publikováno v:
Biomedicines [Biomedicines] 2018 May 17; Vol. 6 (2). Date of Electronic Publication: 2018 May 17.